Evidence map›Paper›PMID 41741444›Full record

ArticleNature communications2026

Copper-catalysed dynamic kinetic (4+1) cyclization of 1,3-enynes for atroposelective arylpyrrole synthesis.

Ya-Jun Zhong, Xiaoli Ren, Ting Qi, Ronggen Zhong, Qian Liu, Lei Hu, Wei Huang, Cheng Peng, Jun-Long Li, Bo Han and 1 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ya-Jun ZhongState Key Laboratory of Southwestern Chinese Medicine Resources, Hospital of Chengdu University of Traditional Chinese Medicine, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.ORCID http://orcid.org/0009-0009-8971-9049
Xiaoli RenState Key Laboratory of Southwestern Chinese Medicine Resources, Hospital of Chengdu University of Traditional Chinese Medicine, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.ORCID http://orcid.org/0009-0003-5614-234X
Ting QiAnti-Infective Agent Creation Engineering Research Centre of Sichuan Province, Sichuan Industrial Institute of Antibiotics, School of Pharmacy, Chengdu University, Chengdu, China.
Ronggen ZhongState Key Laboratory of Southwestern Chinese Medicine Resources, Hospital of Chengdu University of Traditional Chinese Medicine, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Qian LiuState Key Laboratory of Southwestern Chinese Medicine Resources, Hospital of Chengdu University of Traditional Chinese Medicine, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.ORCID http://orcid.org/0000-0002-9999-7781
Lei HuState Key Laboratory of Southwestern Chinese Medicine Resources, Hospital of Chengdu University of Traditional Chinese Medicine, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Wei HuangState Key Laboratory of Southwestern Chinese Medicine Resources, Hospital of Chengdu University of Traditional Chinese Medicine, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.ORCID http://orcid.org/0000-0003-0832-1864
Cheng PengState Key Laboratory of Southwestern Chinese Medicine Resources, Hospital of Chengdu University of Traditional Chinese Medicine, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Jun-Long LiAnti-Infective Agent Creation Engineering Research Centre of Sichuan Province, Sichuan Industrial Institute of Antibiotics, School of Pharmacy, Chengdu University, Chengdu, China.ORCID http://orcid.org/0000-0002-4700-0142
Bo HanState Key Laboratory of Southwestern Chinese Medicine Resources, Hospital of Chengdu University of Traditional Chinese Medicine, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China. hanbo@cdutcm.edu.cn.ORCID http://orcid.org/0000-0003-3200-4682
Gu ZhanState Key Laboratory of Southwestern Chinese Medicine Resources, Hospital of Chengdu University of Traditional Chinese Medicine, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China. zhangu@cdutcm.edu.cn.ORCID http://orcid.org/0000-0002-5263-8263

Funding

Basic Research Programs of Sichuan Province 2024NSFSC0282Basic Research Programs of Sichuan Province 2024NSFTD0023National Natural Science Foundation of China (National Science Foundation of China) 22371021
6 · The paper itself

Abstract

Axially chiral arylpyrroles are a promising class of compounds with broad applications in catalysis, medicinal chemistry, and materials science. Herein, we report a copper-catalysed dynamic kinetic asymmetric (4 + 1) cyclization for the atroposelective synthesis of arylpyrroles bearing a single stereogenic axis or 1,2-diaxes from 1,3-enynes and amines. This dynamic kinetic asymmetric transformation employs a chiral Cu/Pybox complex, with air as the oxidant and DABCO serving as both a base and a proton shuttle. A key feature is the reversibility of the aza-Michael addition, which enables the dynamic formation/cleavage of distal C-N bonds. The 5-endo-dig cyclization serves as both the rate-determining and stereodetermining step, ensuring precise stereocontrol of the proximal stereocenters by the catalyst. This strategy overcomes long-standing challenges in the stereocontrol of distal C-N bond formation and enables the synthesis of atropisomeric DMAP catalysts with two stereogenic axes. DFT calculations provide insights into the mechanism of stereocontrol.

Identifiers

PMID41741444
PMCPMC13056997

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.